In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat.
Desiree Dos Santos NunesLuiza M HigaRégis Linhares OliveiraLendel Correia da CostaLarissa Maciel BomfimCássia Cristina Alves GonçalvesDiana MarianiDennis E HrubyCarolina Moreira VolochTerezinha Marta Pereira Pinto CastiñeirasAmilcar TanuriClarissa R DamasoPublished in: Memorias do Instituto Oswaldo Cruz (2023)
Our results support screening different MPXV isolates for tecovirimat susceptibility as an important tool to better use of the restricted number of tecovirimat doses available in low-income countries to treat patients with mpox.